Apolipoprotein E Gene Variation in Pakistani Subjects with Type 2 Diabetes with and without Cardiovascular Complications

被引:1
|
作者
Nadeem, Shehwar [1 ]
Maqbool, Tahir [1 ]
Qureshi, Javed Anver [1 ]
Altaf, Awais [1 ]
Naz, Sadia [2 ]
Azhar, Muzammal Mateen [2 ]
Ullah, Inam [1 ]
Shah, Tawaf Ali [3 ]
Qamar, Muhammad Usman [4 ,5 ]
Salamatullah, Ahmad Mohammad [6 ]
机构
[1] Univ Lahore, Ctr Res Mol Med, Inst Mol Biol & Biotechnol, Lahore 54660, Pakistan
[2] Univ Lahore, Dept Allied Hlth Sci, Lahore 54660, Pakistan
[3] Shandong Univ Technol, Coll Agr Engn & Food Sci, Zibo 255049, Peoples R China
[4] Univ Geneva, Dept Med, Div Infect Dis, CH-1211 Geneva, Switzerland
[5] Govt Coll Univ Faisalabad, Fac Life Sci, Inst Microbiol, Faisalabad 38000, Pakistan
[6] King Saud Univ, Coll Food & Agr Sci, Dept Food Sci & Nutr, Riyadh 11451, Saudi Arabia
来源
MEDICINA-LITHUANIA | 2024年 / 60卷 / 06期
关键词
apolipoprotein E; polymorphisms; ischemic heart disease; stroke; MELLITUS; DYSLIPIDEMIA; EPIDEMIOLOGY; RISK; ASSOCIATION; PREVALENCE; DISEASE;
D O I
10.3390/medicina60060961
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Apolipoprotein E (APOE) gene polymorphism has been implicated in the pathogenesis of various metabolic disorders, including type 2 diabetes mellitus (T2DM). Type 2 diabetes mellitus (T2DM) is a major public health concern worldwide, including in Pakistan. Cardiovascular problems linked with T2DM have a significant impact on individuals and society. The goal of this study is to investigate the relationship between Apolipoprotein E (ApoE) genotypes, dyslipidemia, and cardiovascular complications such as ischemic heart disease (IHD) and stroke. Methods: This study was carried out on 260 subjects divided into controls and diabetics. The diabetics were further divided into four subgroups such as D1: diabetics without cardiovascular issues, D2: diabetics with heart disease, D3: diabetics with stroke, and D4: diabetics with both heart disease and stroke. Anthropometric parameters (age, BMI) and risk factors (smoking, diabetes duration, hypertension) were assessed in all groups. Serum levels of TC, TG, LDL, HDL, VLDL, creatinine, BSF, and HbA1c were also measured. Apolipoprotein E gene polymorphism was determined using PCR-RFLP. Results: Hypertension, BMI, and dyslipidemia are defined as elevated levels of total cholesterol, triglycerides, LDL, and VLDL, and decreased levels of HDL. Uncontrolled hyperglycemia (elevated fasting blood sugar and glycated hemoglobin) in T2DM was linked to vascular complications such as IHD and stroke. Hypertension was prevalent in 79.3% of the population. Stage 2 hypertension was more prevalent in all age groups. It was also noted that common genotypes in the Pakistani population are 3/3, 4/4, 2/3, and 3/4. The frequency of genotypes 3/4 and 2/3 is highest in diabetics with stroke. Genotype 3/3 is present frequently in diabetics with IHD/stroke and patients with both these complications. However, genotype 4/4 is most frequently found in diabetics with IHD. Conclusions: It is concluded that BMI, hypertension, hyperglycemia, atherosclerosis, and dyslipidemia are linked with cardiovascular complications of type 2 diabetes. Apolipoprotein E gene polymorphism is associated with cardiovascular disease in patients with diabetes by affecting the lipid profile.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease
    Dalia El-Lebedy
    Hala M. Raslan
    Asmaa M. Mohammed
    Cardiovascular Diabetology, 15
  • [2] Apolipoprotein E gene polymorphism and the risk of cardiovascular disease and type 2 diabetes
    Sudong Liu
    Jing Liu
    Ruiqiang Weng
    Xiaodong Gu
    Zhixiong Zhong
    BMC Cardiovascular Disorders, 19
  • [3] Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease
    El-Lebedy, Dalia
    Raslan, Hala M.
    Mohammed, Asmaa M.
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [4] Apolipoprotein E gene polymorphism and the risk of cardiovascular disease and type 2 diabetes
    Liu, Sudong
    Liu, Jing
    Weng, Ruiqiang
    Gu, Xiaodong
    Zhong, Zhixiong
    BMC CARDIOVASCULAR DISORDERS, 2019, 19 (01)
  • [5] Erratum to: Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease
    Dalia El-Lebedy
    Hala M. Raslan
    Asmaa M. Mohammed
    Cardiovascular Diabetology, 15
  • [6] Diabetes Incidence in Subjects with and without Cardiovascular Complications
    Johansen, Odd Erik
    Ofstad, Anne Pernille
    Sorensen, Monica
    Blaasaas, Karl G.
    Gullestad, Lars
    Birkeland, Kare I.
    DIABETES, 2009, 58 : A550 - A550
  • [7] Apolipoprotein E (ApoE) gene polymorphism and the development of diabetic complications in Type I and Type 2 diabetes
    Miccoli, R
    Pucci, L
    Lucchesi, D
    Grupillo, M
    Fotino, C
    Triscomia, S
    Giannarelli, R
    Giovannitti, G
    Penno, G
    Del Prato, S
    DIABETOLOGIA, 2002, 45 : A346 - A346
  • [8] Type 2 diabetes mellitus and its renal complications in relation to apolipoprotein E gene polymorphism
    Ma, Shuk-Woon
    Benzie, Iris F. F.
    Yeung, Vincent T. F.
    TRANSLATIONAL RESEARCH, 2008, 152 (03) : 134 - 142
  • [9] Apolipoprotein E gene polymorphism and its effect on anthropometric measures in normoglycemic subjects and type 2 diabetes
    Tabatabaei-Malazy O.
    Fakhrzadeh H.
    Qorbani M.
    Amiri P.
    Larijani B.
    Tavakkoly-Bazzaz J.
    Amoli M.M.
    Journal of Diabetes & Metabolic Disorders, 11 (1):
  • [10] Cardiovascular risk factors in patients of type 2 diabetes mellitus with and without cardiovascular complications
    Aasvee, KE
    Kurvinen, E
    Roovere, T
    Tupits, H
    Hedman, A
    Jauhiainen, M
    Sundvall, J
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 152 - 152